Factors Associated With Failure of HFNO in COVID-19 ICU Patients

NCT05798234 — Unknown, 500 participants, Central Hospital, Nancy, France

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Registry	NCT05798234, acronym CO-OHD
Status	Unknown
Study type	Observational
Enrollment	500 (Estimated)
Sponsor	Central Hospital, Nancy, France (Other)
Conditions	COVID-19 Pneumonia
Interventions	high flow oxygen device (Device)
Dates	start 2023-05-01 (estimated), primary completion 2023-09-01 (estimated), completion 2023-12-01 (estimated), first posted 2023-04-04, last updated 2023-04-04
Locations	1 site in France

-Summary

To determine the factors associated with OHD failure in COVID-19 patients admitted to an Intensive Care Unit

Expand all sections · Collapse all

+Detailed description

Patients admitted into 1 participating ICU for acute hypoxemic respiratory failure due to COVID-19 between 02/01/2020 and 06/01/2022 will be assessed for OHD failure

+Arms and interventions

high flow oxygen device (Device): no intervention

+Outcome measures

Primary outcomes

High flow oxygen failure [icu stay duration]: patients requiring initial high flow oxygen but finally intubated

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients admitted in ICU for COVID-19 pneumonia

Exclusion Criteria:

* under immediate ECMO
* secondary transferred from another ICU
* readmission in the ICU
* initial limitation of care

+Locations (1)

Facility	City	Country	Status
Service de Réanimation Médicale, Hôpital Central	Nancy	France

My Notes

Public

To Read Reading Read